CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

ADXNAddex Therapeutics Ltd.

NASDAQ · Pharmaceutical Preparations
Last close $2.76 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
RECENT INSIDER TRADES
  • 2026-09-04 · Mills Roger (CHIEF MEDICAL OFFICER) · OTHER
  • 2026-09-04 · Kalinichev Mikhail (HEAD OF TRANSLATIONAL SCIENCE) · OTHER
  • 2026-09-04 · Hill Raymond George (Director) · OTHER
  • 2026-09-04 · Lawton Vincent Michael (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders2
Shares held48
Value$274
Percent of shares outstanding0.00%
As of quarter end2026-06-30
RECENT NEWS
  • Addex Therapeutics Announces Executive Management Changes
  • Addex Therapeutics reports Q2 2026 results
  • ADXN halted · Volatility pause (LULD)
  • Addex Therapeutics shares fall on H1 2026 update and funding focus
  • Addex Therapeutics reports 1H results
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Addex Therapeutics Ltd. (ADXN) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit